Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans. This report contains market size and forecasts of Human Insulin in global, including the following market information: Global Human Insulin Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Human Insulin Market Sales, 2017-2022, 2023-2028, (K Doses) Global top five Human Insulin companies in 2021 (%) The global Human Insulin market was valued at 57460 million in 2021 and is projected to reach US$ 104760 million by 2028, at a CAGR of 9.0% during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Insulin Analogs and Biosimilars Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Human Insulin include B. Braun, Becton, Dickinson, Biocon, Biodel, ELI Lilly, Julphar, NOVO Nordisk, Sanofi and Wockhardt and etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Insulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Human Insulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses) Global Human Insulin Market Segment Percentages, by Type, 2021 (%) Insulin Analogs and Biosimilars Human Insulin Biologics Global Human Insulin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses) Global Human Insulin Market Segment Percentages, by Application, 2021 (%) Short Acting Intermediate Acting Long Acting Pre-Mix Insulin Global Human Insulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses) Global Human Insulin Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Human Insulin revenues in global market, 2017-2022 (Estimated), ($ millions) Key companies Human Insulin revenues share in global market, 2021 (%) Key companies Human Insulin sales in global market, 2017-2022 (Estimated), (K Doses) Key companies Human Insulin sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: B. Braun Becton, Dickinson Biocon Biodel ELI Lilly Julphar NOVO Nordisk Sanofi Wockhardt Ypsomed
1 Introduction to Research & Analysis Reports 1.1 Human Insulin Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Human Insulin Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year
